Gilead strikes deal to make remdesivir coronavirus treatment in 127 countries – CNBC
Business News
- Gilead strikes deal to make remdesivir coronavirus treatment in 127 countries CNBC
- Gilead announces non-U.S. deals with five generic drugmakers for remdesivir MarketWatch
- MSNBC public editor: Who benefits from remdesivir coverage? Columbia Journalism Review
- India’s Jubilant signs licensing deal for Gilead’s COVID-19 drug Reuters
- Gilead inks deals with generics makers to supply COVID-19 therapy remdesivir for 127 countries FiercePharma
- View Full Coverage on Google News
Source: Business News